CASSANDRA BAIER: Open Payments
NPI 1396289674 · POTTSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,773 in 91 payments from 16 companies in 2025. Trend: 2023 $1,416 · 2024 $1,464 · 2025 $1,773
Food & beverage: $1,567Education: $206
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $374 |
| GENZYME CORPORATION | 10 | $325 |
| ABBVIE INC. | 24 | $263 |
| Regeneron Healthcare Solutions, Inc. | 7 | $238 |
| Galderma Laboratories, L.P. | 15 | $184 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| UCB, Inc. | 3 | $59 |
| Organon LLC | 4 | $56 |
| LEO Pharma Inc. | 2 | $42 |
| Verrica Pharmaceuticals Inc. | 2 | $33 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, NEMLUVIO, AKLIEF, RINVOQ, Bimzelx, COSENTYX.
Industry payments across PA — which companies pay providers there.
